Information Processing Speed in Ecstasy (MDMA) Users

M. Wareing, J. Fisk, C. Montgomery, P. Murphy, M. Chandler

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Previous research draws parallels between ecstasy-related and age-related deficits in cognitive functioning. Age-related impairments in working memory have been attributed to a slow down in information processing speed. The present study compared 29 current ecstasy users, 10 previous users and 46 non-users on two tests measuring information processing speed and a computation span task measuring working memory. Results showed that ecstasy users performed worse than non-ecstasy users in the letter comparison task although the overall difference was not significant (p = 0.089). Results from the pattern recognition task showed that current ecstasy users produced significantly more errors than the other two groups (p < 0.01). When results were combined for both the letter and pattern tasks, once again current ecstasy users produced significantly more errors than non-ecstasy users (p < 0.01). Working memory deficits obtained were statistically significant with both ecstasy using groups performing significantly worse than non-users on the computation span measure (p < 0.01). Moreover, ANCOVA with measures of processing speed as covariates failed to eliminate the group difference in computation span (p < 0.01). Therefore, it is likely the mechanism responsible for impairments in the computation span measure is not the same as that in elderly adults where processing speed generally removes most of the age-related variance. Also of relevance is the fact that the ecstasy users reported here had used a range of other drugs making it difficult to unambiguously attribute the results obtained to ecstasy use.
Original languageEnglish
Pages (from-to)81-88
JournalHuman Psychopharmacology: Clinical and Experimental
Volume22
Issue number2
DOIs
Publication statusPublished - 12 Feb 2007

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Automatic Data Processing
Short-Term Memory
Memory Disorders
Research
Pharmaceutical Preparations

Cite this

Wareing, M. ; Fisk, J. ; Montgomery, C. ; Murphy, P. ; Chandler, M. / Information Processing Speed in Ecstasy (MDMA) Users. In: Human Psychopharmacology: Clinical and Experimental. 2007 ; Vol. 22, No. 2. pp. 81-88.
@article{734eedb177624c5fac41c2890a528e7e,
title = "Information Processing Speed in Ecstasy (MDMA) Users",
abstract = "Previous research draws parallels between ecstasy-related and age-related deficits in cognitive functioning. Age-related impairments in working memory have been attributed to a slow down in information processing speed. The present study compared 29 current ecstasy users, 10 previous users and 46 non-users on two tests measuring information processing speed and a computation span task measuring working memory. Results showed that ecstasy users performed worse than non-ecstasy users in the letter comparison task although the overall difference was not significant (p = 0.089). Results from the pattern recognition task showed that current ecstasy users produced significantly more errors than the other two groups (p < 0.01). When results were combined for both the letter and pattern tasks, once again current ecstasy users produced significantly more errors than non-ecstasy users (p < 0.01). Working memory deficits obtained were statistically significant with both ecstasy using groups performing significantly worse than non-users on the computation span measure (p < 0.01). Moreover, ANCOVA with measures of processing speed as covariates failed to eliminate the group difference in computation span (p < 0.01). Therefore, it is likely the mechanism responsible for impairments in the computation span measure is not the same as that in elderly adults where processing speed generally removes most of the age-related variance. Also of relevance is the fact that the ecstasy users reported here had used a range of other drugs making it difficult to unambiguously attribute the results obtained to ecstasy use.",
author = "M. Wareing and J. Fisk and C. Montgomery and P. Murphy and M. Chandler",
year = "2007",
month = "2",
day = "12",
doi = "10.1002/hup.827",
language = "English",
volume = "22",
pages = "81--88",
journal = "Human Psychopharmacology",
issn = "0885-6222",
publisher = "John Wiley & Sons",
number = "2",

}

Information Processing Speed in Ecstasy (MDMA) Users. / Wareing, M.; Fisk, J.; Montgomery, C.; Murphy, P.; Chandler, M.

In: Human Psychopharmacology: Clinical and Experimental, Vol. 22, No. 2, 12.02.2007, p. 81-88.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Information Processing Speed in Ecstasy (MDMA) Users

AU - Wareing, M.

AU - Fisk, J.

AU - Montgomery, C.

AU - Murphy, P.

AU - Chandler, M.

PY - 2007/2/12

Y1 - 2007/2/12

N2 - Previous research draws parallels between ecstasy-related and age-related deficits in cognitive functioning. Age-related impairments in working memory have been attributed to a slow down in information processing speed. The present study compared 29 current ecstasy users, 10 previous users and 46 non-users on two tests measuring information processing speed and a computation span task measuring working memory. Results showed that ecstasy users performed worse than non-ecstasy users in the letter comparison task although the overall difference was not significant (p = 0.089). Results from the pattern recognition task showed that current ecstasy users produced significantly more errors than the other two groups (p < 0.01). When results were combined for both the letter and pattern tasks, once again current ecstasy users produced significantly more errors than non-ecstasy users (p < 0.01). Working memory deficits obtained were statistically significant with both ecstasy using groups performing significantly worse than non-users on the computation span measure (p < 0.01). Moreover, ANCOVA with measures of processing speed as covariates failed to eliminate the group difference in computation span (p < 0.01). Therefore, it is likely the mechanism responsible for impairments in the computation span measure is not the same as that in elderly adults where processing speed generally removes most of the age-related variance. Also of relevance is the fact that the ecstasy users reported here had used a range of other drugs making it difficult to unambiguously attribute the results obtained to ecstasy use.

AB - Previous research draws parallels between ecstasy-related and age-related deficits in cognitive functioning. Age-related impairments in working memory have been attributed to a slow down in information processing speed. The present study compared 29 current ecstasy users, 10 previous users and 46 non-users on two tests measuring information processing speed and a computation span task measuring working memory. Results showed that ecstasy users performed worse than non-ecstasy users in the letter comparison task although the overall difference was not significant (p = 0.089). Results from the pattern recognition task showed that current ecstasy users produced significantly more errors than the other two groups (p < 0.01). When results were combined for both the letter and pattern tasks, once again current ecstasy users produced significantly more errors than non-ecstasy users (p < 0.01). Working memory deficits obtained were statistically significant with both ecstasy using groups performing significantly worse than non-users on the computation span measure (p < 0.01). Moreover, ANCOVA with measures of processing speed as covariates failed to eliminate the group difference in computation span (p < 0.01). Therefore, it is likely the mechanism responsible for impairments in the computation span measure is not the same as that in elderly adults where processing speed generally removes most of the age-related variance. Also of relevance is the fact that the ecstasy users reported here had used a range of other drugs making it difficult to unambiguously attribute the results obtained to ecstasy use.

U2 - 10.1002/hup.827

DO - 10.1002/hup.827

M3 - Article

VL - 22

SP - 81

EP - 88

JO - Human Psychopharmacology

JF - Human Psychopharmacology

SN - 0885-6222

IS - 2

ER -